Michael H Criqui1, Julie O Denenberg2, Joachim H Ix3, Robyn L McClelland4, Christina L Wassel5, Dena E Rifkin3, Jeffrey J Carr6, Matthew J Budoff7, Matthew A Allison2. 1. Department of Family and Preventive Medicine, University of California, San Diego, La Jolla2Department of Medicine, University of California, San Diego, La Jolla. 2. Department of Family and Preventive Medicine, University of California, San Diego, La Jolla. 3. Department of Medicine, University of California, San Diego, La Jolla. 4. Department of Biostatistics, University of Washington, Seattle. 5. Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania. 6. Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, Tennessee. 7. Division of Cardiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles.
Abstract
IMPORTANCE: Coronary artery calcium (CAC), measured by computed tomography (CT), has strong predictive value for incident cardiovascular disease (CVD) events. The standard CAC score is the Agatston, which is weighted upward for greater calcium density. However, some data suggest increased plaque calcium density may be protective for CVD. OBJECTIVE: To determine the independent associations of CAC volume and CAC density with incident CVD events. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, prospective observational MESA study (Multi-Ethnic Study of Atherosclerosis), conducted at 6 US field centers of 3398 men and women from 4 race/ethnicity groups; non-Hispanic white, African American, Hispanic, and Chinese. Participants were aged 45-84 years, free of known CVD at baseline, had CAC greater than 0 on their baseline CT, and were followed up through October 2010. MAIN OUTCOMES AND MEASURES: Incident coronary heart disease (CHD) and all CVD events RESULTS: During a median of 7.6 years of follow-up, there were 175 CHD events and an additional 90 other CVD events for a total of 265 CVD events. With both lnCAC volume and CAC density scores in the same multivariable model, the lnCAC volume score showed an independent association with incident CHD, with a hazard ratio (HR) of 1.81 (95% CI, 1.47-2.23) per standard deviation (SD = 1.6) increase, absolute risk increase 6.1 per 1000 person-years, and for CVD an HR of 1.68 (95% CI, 1.42-1.98) per SD increase, absolute risk increase 7.9 per 1000 person-years. Conversely, the CAC density score showed an independent inverse association, with an HR of 0.73 (95% CI, 0.58-0.91) per SD (SD = 0.7) increase for CHD, absolute risk decrease 5.5 per 1000 person-years, and an HR of 0.71 (95% CI, 0.60-0.85) per SD increase for CVD, absolute risk decrease 8.2 per 1000 person years. Area under the receiver operating characteristic curve analyses showed significantly improved risk prediction with the addition of the density score to a model containing the volume score for both CHD and CVD. In the intermediate CVD risk group, the area under the curve for CVD increased from 0.53 (95% CI, 0.48-0.59) to 0.59 (95% CI, 0.54-0.64), P = .02. CONCLUSIONS AND RELEVANCE: CAC volume was positively and independently associated with CHD and CVD risk. At any level of CAC volume, CAC density was inversely and significantly associated with CHD and CVD risk. The role of CAC density should be considered when evaluating current CAC scoring systems.
IMPORTANCE: Coronary artery calcium (CAC), measured by computed tomography (CT), has strong predictive value for incident cardiovascular disease (CVD) events. The standard CAC score is the Agatston, which is weighted upward for greater calcium density. However, some data suggest increased plaque calcium density may be protective for CVD. OBJECTIVE: To determine the independent associations of CAC volume and CAC density with incident CVD events. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, prospective observational MESA study (Multi-Ethnic Study of Atherosclerosis), conducted at 6 US field centers of 3398 men and women from 4 race/ethnicity groups; non-Hispanic white, African American, Hispanic, and Chinese. Participants were aged 45-84 years, free of known CVD at baseline, had CAC greater than 0 on their baseline CT, and were followed up through October 2010. MAIN OUTCOMES AND MEASURES: Incident coronary heart disease (CHD) and all CVD events RESULTS: During a median of 7.6 years of follow-up, there were 175 CHD events and an additional 90 other CVD events for a total of 265 CVD events. With both lnCAC volume and CAC density scores in the same multivariable model, the lnCAC volume score showed an independent association with incident CHD, with a hazard ratio (HR) of 1.81 (95% CI, 1.47-2.23) per standard deviation (SD = 1.6) increase, absolute risk increase 6.1 per 1000 person-years, and for CVD an HR of 1.68 (95% CI, 1.42-1.98) per SD increase, absolute risk increase 7.9 per 1000 person-years. Conversely, the CAC density score showed an independent inverse association, with an HR of 0.73 (95% CI, 0.58-0.91) per SD (SD = 0.7) increase for CHD, absolute risk decrease 5.5 per 1000 person-years, and an HR of 0.71 (95% CI, 0.60-0.85) per SD increase for CVD, absolute risk decrease 8.2 per 1000 person years. Area under the receiver operating characteristic curve analyses showed significantly improved risk prediction with the addition of the density score to a model containing the volume score for both CHD and CVD. In the intermediate CVD risk group, the area under the curve for CVD increased from 0.53 (95% CI, 0.48-0.59) to 0.59 (95% CI, 0.54-0.64), P = .02. CONCLUSIONS AND RELEVANCE: CAC volume was positively and independently associated with CHD and CVD risk. At any level of CAC volume, CAC density was inversely and significantly associated with CHD and CVD risk. The role of CAC density should be considered when evaluating current CAC scoring systems.
Authors: Alexander W Leber; Andreas Knez; Carl W White; Alexander Becker; Franz von Ziegler; Olaf Muehling; Christoph Becker; Maximilian Reiser; Gerhard Steinbeck; Peter Boekstegers Journal: Am J Cardiol Date: 2003-03-15 Impact factor: 2.778
Authors: Robert C Detrano; Melissa Anderson; Jennifer Nelson; Nathan D Wong; J Jeffrey Carr; Michael McNitt-Gray; Diane E Bild Journal: Radiology Date: 2005-06-21 Impact factor: 11.105
Authors: Joseph Yeboah; Robyn L McClelland; Tamar S Polonsky; Gregory L Burke; Christopher T Sibley; Daniel O'Leary; Jeffery J Carr; David C Goff; Philip Greenland; David M Herrington Journal: JAMA Date: 2012-08-22 Impact factor: 56.272
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: C Jason Liang; Matthew J Budoff; Joel D Kaufman; Richard A Kronmal; Elizabeth R Brown Journal: BMC Med Imaging Date: 2012-07-02 Impact factor: 1.930
Authors: Bálint Szilveszter; Hesham Elzomor; Mihály Károlyi; Márton Kolossváry; Rolf Raaijmakers; Kálmán Benke; Csilla Celeng; Andrea Bartykowszki; Zsolt Bagyura; Árpád Lux; Béla Merkely; Pál Maurovich-Horvat Journal: Int J Cardiovasc Imaging Date: 2015-08-19 Impact factor: 2.357
Authors: Hartmut H Malluche; Gustav Blomquist; Marie-Claude Monier-Faugere; Thomas L Cantor; Daniel L Davenport Journal: J Am Soc Nephrol Date: 2015-04-02 Impact factor: 10.121
Authors: Margaret A Crawford; Michael H Criqui; Nketi Forbang; Jonathan T Unkart; Matthew A Allison; Britta A Larsen Journal: Metabolism Date: 2020-04-13 Impact factor: 8.694
Authors: Ryo Kawakami; Shunsuke Katsuki; Richard Travers; Dayanna Carolina Romero; Dakota Becker-Greene; Livia Silva Araujo Passos; Hideyuki Higashi; Mark C Blaser; Galina K Sukhova; Josef Buttigieg; David Kopriva; Ann Marie Schmidt; Daniel G Anderson; Sasha A Singh; Luis Cardoso; Sheldon Weinbaum; Peter Libby; Masanori Aikawa; Kevin Croce; Elena Aikawa Journal: Arterioscler Thromb Vasc Biol Date: 2020-05-28 Impact factor: 8.311
Authors: Jessica B Kendrick; Leila Zelnick; Michel B Chonchol; David Siscovick; Andrew N Hoofnagle; Joachim H Ix; Mark Sarnak; Michael G Shlipak; Bryan Kestenbaum; Ian H de Boer Journal: Am J Nephrol Date: 2016-12-10 Impact factor: 3.754